Factors associated with mortality in cirrhotic patients

Authors

Keywords:

cirrhosis, hepatic cirrhosis, mortality.

Abstract

Introduction: Liver cirrhosis represents 9,1 % of causes of mortality in Peru. There is little evidence on the influence of epidemiological and clinical variables on the mortality of patients with liver cirrhosis in Latin America, especially in developing countries such as Peru.
Objective: To identify the factors associated with mortality in cirrhotic patients.
Methods: Cross-sectional study in cirrhotic patients treated at the Cayetano Heredia Hospital in Piura, Peru, year 2017. The dependent variable was hospital mortality and the independent variables were epidemiological, clinical and laboratory characteristics. Fisher's exact test and the T test were used to estimate the factors associated with mortality.
Results: Of 52 patients, the frequency of mortality due to cirrhosis was 35,4 %. Have moderate ascites (p=0,004), degree of encephalopathy (p=0,001), leukocytosis (p=0,004), decompensated disease according to the Child Pugh index (p=0,023), Meld index between 30-39 points (p<0,001) and creatinine levels (p=0,009) were associated with a higher frequency of mortality.
Conclusion: The presence of moderate ascites, degree of encephalopathy, leukocytosis, decompensated disease according to the Child Pugh index, Meld index between 30-39, creatinine levels are associated with mortality in cirrhotic patients.

Downloads

Download data is not yet available.

References

1. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019 [acceso: 23/03/2021];70(1):151-71. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30266282/

2. Castillo-Contreras O, Flores-Flores C. Mortalidad por enfermedades digestivas no neoplásicas en la población adulta del Perú, 2010 - 2015. Anales de la Facultad de Medicina. 2019 [acceso: 23/03/2021]; 80(1): 39-44. Disponible en: http://www.scielo.org.pe/scielo.php?pid=S1025-55832019000100007&script=sci_abstract

3. Bustíos C, Dávalos M, Román R, Zumaeta E. Características Epidemiológicas y Clínicas de la Cirrosis Hepática en la Unidad de Hígado del HNERM Es-Salud. Revista de Gastroenterología del Perú. 2007 [acceso: 23/03/2021]; 27(3): 238-45. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292007000300003

4. Charatcharoenwitthaya P, Soonthornworasiri N, Karaketklang K, Poovorawan K, Pan-Ngum W, Chotiyaputta W, et al. Factors affecting mortality and resource use for hospitalized patients with cirrhosis: A population-based study. Medicine (Baltimore). 2017 [acceso: 23/03/2021]; 96(32):e7782. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28796076/

5. Levesque E, Hoti E, Azoulay D, Ichaï P, Habouchi H, Castaing D, et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol. 2012 [acceso: 23/03/2021]; 56(1):95-102. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21835136/

6. Uslan I, Olt S, Eminler AT. Which Factors are Predictive for Mortality among Hospitalized Patients with Cirrhosis? Hepatogastroenterology. 2015 [acceso: 23/03/2021]; 62(140):1023-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26902049/

7. Di Martino V, Weil D, Cervoni J-P, Thevenot T. New prognostic markers in liver cirrhosis. World J Hepatol. 2015 [acceso: 23/03/2021]; 7(9):1244-50. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26019739/

8. Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, et al. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2009 [acceso: 23/03/2021]; 7(6):689-95. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19281860/

9. Melcarne L, Sopeña J, Martínez-Cerezo F-J, Vergara M, Miquel M, Sánchez-Delgado J, et al. Factores pronósticos de mortalidad en la cirrosis hepática tras un primer episodio de peritonitis bacteriana espontánea. Estudio multicéntrico. Rev Esp Enferm Dig. 2018 [acceso: 23/03/2021]; 110(2):94-101. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082018000200005

10. Ximenes RO, Farias AQ, Scalabrini Neto A, Diniz MA, Kubota GT, Ivo MMA-A, et al. Patients with cirrhosis in the ED: early predictors of infection and mortality. Am J Emerg Med. 2016 [acceso: 23/03/2021]; 34(1):25-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26423777/

11. Gessolo Lins PR, Carvalho Padilha WS, Magalhaes Giradin Pimentel CF, Costa Batista M, Teixeira de Gois AF. Risk factors, mortality and acute kidney injury outcomes in cirrhotic patients in the emergency department. BMC Nephrol. 2018 [acceso: 23/03/2021]; 19(1):277. Disponible en: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-018-1061-8

12. Nuthalapati A, Schluterman N, Khanna A, Greenberg D, Thuluvath PJ. Impact of Acute Kidney Injury on Mortality of Patients Hospitalized for Complications of Cirrhosis. Journal of Clinical and Experimental Hepatology. 2017 [acceso: 23/03/2021]; 7(4):290-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29234192/

13. Fayad L, Narciso-Schiavon JL, Lazzarotto C, Ronsoni MF, Wildner LM, Bazzo ML, et al. The performance of prognostic models as predictors of mortality in patients with acute decompensation of cirrhosis. Annals of Hepatology. 2015 [acceso: 23/03/2021]; 14(1):83-92. Disponible en: https://www.elsevier.es/en-revista-annals-hepatology-16-articulo-the-performance-prognostic-models-as-S166526811930804X

14. Zubieta-Rodríguez R, Gómez-Correa J, Rodríguez-Amaya R, Ariza-Mejia KA, Toloza-Cuta NA. Mortalidad hospitalaria en pacientes cirróticos en un hospital de tercer nivel. Rev Gastroenterol Mex. 2017 [acceso: 23/03/2021]; 82(3):203-9. Disponible en: http://www.revistagastroenterologiamexico.org/es-mortalidad-hospitalaria-pacientes-cirroticos-un-articulo-S0375090617300010

15. Rosado Cipriano M, García-Encinas C, Bellido-Caparó Á, Purizaca Navarro A, Valenzuela Granados V. Frecuencia, perfil clínico y mortalidad de la insuficiencia hepática crónica reagudizada en un hospital público de Lima - Perú. Revista de Gastroenterología del Perú. 2018 [acceso: 23/03/2021]; 38(4):325-30. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292018000400002

16. Malpica-Castillo A, Ticse R, Salazar-Quiñones M, Cheng-Zárate L, Valenzuela-Granados V, Huerta-Mercado Tenorio J. Mortalidad y readmisión en pacientes cirróticos hospitalizados en un hospital general de Lima, Perú. Revista de Gastroenterología del Perú. 2013 [acceso: 23/03/2021]; 33(4):301-5. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292013000400003

17. Ruiz García S, Castillo Núñez L, Malca Atoche J, Valderrama Ascoy J, Aguilar Saldaña G. Predictores de infección y mortalidad en pacientes con cirrosis hepática en el hospital de alta complejidad Virgen de la Puerta de Trujillo, Perú. Revista de Gastroenterología del Perú. 2019 [acceso: 23/03/2021]; 39(1):55-63. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292019000100008

18. Huang Y-F, Lin C-S, Cherng Y-G, Yeh C-C, Chen R-J, Chen T-L, et al. A population-based cohort study of mortality of intensive care unit patients with liver cirrhosis. BMC Gastroenterol. 2020 [acceso: 23/03/2021]; 20(1):15. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31948392/

19. Gaspar R, Rodrigues S, Silva M, Costa-Moreira P, Morais R, Andrade P, et al. Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis. Dig Liver Dis. 2019 [acceso: 23/03/2021]; 51(10):1423-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31113738/

20. Javaud N, Bonnin L, Lapostolle F, Boubaya M, Bardis A, Dufau R, et al. Prognosis of cirrhotic patients admitted to Emergency Departments: A multicenter study. 2019 [acceso: 23/03/2021]; 37(7):1317-21. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30337088/

21. Planas R, Montoliu S, Ballesté B, Rivera M, Miquel M, Masnou H, et al. Natural History of Patients Hospitalized for Management of Cirrhotic Ascites. Clin Gastroenterol Hepatol. 2004 [acceso: 23/03/2021]; 4:1385‐1394. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17081806/

22. Scaglione SJ, Metcalfe L, Kliethermes S, Vasilyev I, Tsang R, Caines A, et al. Early Hospital Readmissions and Mortality in Patients With Decompensated Cirrhosis Enrolled in a Large National Health Insurance Administrative Database. Journal of Clinical Gastroenterology. 2017 [acceso: 23/03/2021]; 51(9):839-44. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28383303/

23. Kudru CU, Eshwara VK, Nagiri SK, Guddattu V. Spectrum of bacterial infections and predictors of mortality in adult cirrhotic patients. Med Pharm Rep. 2019 [acceso: 23/03/2021]; 92(4):356-61. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31750435/

24. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen K, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014 [acceso: 23/03/2021]; 60(2):715-35. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25042402/

25. Attia K, Ackoundou-N'guessan K, N'dri-yoman A, Mahassadi A, Messou E, Bathaix Y, et al. Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. World J Gastroenterol. 2008 [acceso: 23/03/2021]; 14(2):286-91. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18186569/

26. Valenzuela Granados V, Salazar-Quiñones M, Cheng-Zárate L, Malpica-Castillo A, Huerta Mercado J, Ticse R. Comparación del valor pronóstico de mortalidad del Score Child Pugh y los modelos de pronóstico de enfermedad hepática crónica en pacientes con cirrosis hepática descompensada del Hospital Nacional Cayetano Heredia, Lima-Perú. Revista de Gastroenterología del Perú. 2015 [acceso: 23/03/2021]; 35(4):307-12. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292015000400003

27. Morales BP, Planas R, Bartoli R, Morillas RM, Sala M, Cabré E, et al. Early hospital readmission in decompensated cirrhosis: Incidence, impact on mortality, and predictive factors. Digestive and Liver Disease. 2017 [acceso: 23/03/2021]; 49(8):903-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28410915/

28. Correa S, Ponce de León C, Perendones M. Insuficiencia renal aguda en la cirrosis hepática: análisis de causas. Revista Uruguaya de Medicina Interna. 2016 [acceso: 23/03/2021]; 1(2):20-8. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S2393-67972016000200003

Downloads

Published

2021-08-28

How to Cite

1.
Viera Santillán M, Vasquez Elera L, Valdiviezo Morales C, Martinez Rivera R, Valladares Garrido M. Factors associated with mortality in cirrhotic patients. Rev Cubana Med Milit [Internet]. 2021 Aug. 28 [cited 2025 Apr. 4];50(3):e02101370. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/1370

Issue

Vol. 50 No. 3 (2021): July - September

Section

Research Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.